Skip to content
Modern Choice UK

Giving Stem Cells in Utero to Infants with Spina Bifida Enhances Life Outcomes, Study Reveals

A pioneering medical trial has found that providing pluripotent cells to fetuses suffering from spina bifida while undergoing fetal surgery could constitute a "important advancement" in managing prenatal disorders.

Research Framework and Assurance

The American study examined six developing infants with the 'open' form of spina bifida. Surgeons applied regenerative cells sourced from the maternal placenta directly onto the baby's spinal cord while the defect was being closed.

Importantly, the regenerative treatment demonstrated a favorable safety profile. The study team reported that the treatment did not lead to neoplasms, interfere with wound healing, or impede the resolution of co-occurring hindbrain herniation.

Positive Developments

Post-birth MRI scans confirmed a complete reversal of Chiari malformation in every participant. This brain structure normalization is strongly associated with improved motor skills and quality of life.

"Should it enable more children able to walk who wouldn't have, it could establish itself as their standard of care," commented the principal investigator. "The results are profoundly encouraging and open the door to a variety of prospective novel therapies."

Broader Impact and Encouragement

Independent medical specialists proposed that further confirmation of these noted improvements could herald a "fresh chapter" in fetal surgery. The prospect of enhancing neural deficits present before birth is considered a transformative goal.

Notably important would be advancements for bladder and bowel function, which are typical difficulties for those diagnosed with this defect.

The Path Forward

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals create a solid basis for broader investigative efforts. The combination of regenerative medicine with established fetal surgery techniques holds considerable promise for changing life trajectories for babies yet to be born with myelomeningocele.

CH
Written by

Cassidy Hopkins

Eleanor is a freelance writer and design enthusiast based in London, covering lifestyle and innovation.

Modern Choice UK

Type to search articles.